Abstract:A case of an acute purpuric eruption Editor, A 78-year-old woman was admitted for acute pancreatitis secondary to choledocholithiasis. She also exhibited coffee grounds vomiting and intense anemia, suggestive of lower gastrointestinal bleeding. After 24 hours, confluent violaceous patches appeared on the extensor surface of the extremities and the outer aspect of both breasts. A skin biopsy was consistent at that point with leukocytoclastic vasculitis. The skin lesions rapidly grew worse and became bullous (Figs. 1 and 2). After 48 hours, the patient presented abnormalities in coagulation parameters (activated partial thromoplastin time 44.5 seconds, Quick index 46%), together with leukopenia (1100 cells/mm) and neutropenia (500 cells/mm). Fibrinogen levels were high (669 mg/dl). The patient’s status continued to worsen, and she presented with sudden dyspnea and severe anemia (hemoglobin 4g/dl). Computed tomography pulmonary angiography ruled out pulmonary embolism. A new skin biopsy showed dermal fibrin thrombi and hematic extravasations in keeping with thrombotic vasculopathy. Coagulation study showed positive IgG (30.9 GPLU/ml) and IgM (10.5 MPLU/ml) anticardiolipin antibodies with positive lupus anticoagulant. Three days after admission, the patient died from multiple organ failure. A small subset of patients with APS have widespread thrombotic disease with multi-organ failure, called ‘‘catastrophic antiphospholipid syndrome’’ (CAPS). It is characterized predominantly by small vessel occlusive disease, affecting mainly parenchymal organs. According to the preliminary classification criteria for APS, our patient represented a probable case. We believe that the most likely diagnosis in this emergency room case was CAPS, according to the following criteria: evidence of involvement of three or more organs, systems or tissues; development of manifestations simultaneously or in <1 week and confirmation by histopathology of small vessel occlusion in at least one organ or tissue. The clinical presentation and the abnormalities in the coagulation parameters also suggested a diagnosis of disseminated intravascular coagulation (DIC). Disseminated intravascular coagulation features are not rare in CAPS, which highlights the need for systematic screening of antiphospholipid antibodies in all patients with DIC features without precipitating factors. Acute DIC is confirmed by demonstrating increased thrombin generation (decreased fibrinogen) and increased fibrinolysis; however our patient had elevated fibrinogen. Antiphospholipid syndrome has recently been described in two reports. The lack of any other cause and the existence of anticardiolipin antibody and lupus anticoagulant antibody suggest that thrombosis could be responsible. Livedo reticularis is the most frequently observed cutaneous lesion; other lesions, by order of frequency, are ulcerations, digital gangrene, subungual splinter

A case of an acute purpuric eruption

Prostaglandin F2 alpha output by human endometrium under superfusion and organ culture conditions.

Antiphospholipid Syndrome: a Survey of Clinical Characters in Ten Cases

Re: Oncologic Outcomes following Robot-Assisted Radical Cystectomy with Minimum 5-Year Follow-up: The Roswell Park Cancer Institute Experience.

Stamp2 controls macrophage inflammation through nicotinamide adenine dinucleotide phosphate homeostasis and protects against atherosclerosis.

Extensive Thrombosis in Catastrophic Antiphospholipid Syndrome in a Newly Diagnosed Systemic Lupus Erythematosus: A Case Report

Myocarditis As A Manifestation Of Catastrophic Antiphospholipid Syndrome

A Case of Catastrophic Antiphospholipid Syndrome with Acute Multiorgan Thrombosis and Concerns for Re-Emergence

Antiphospholipid syndrome presenting as extensive skin ulcers on unilateral lower extremity: a case report

Systemic Embolism Following Mechanical Thrombectomy for Acute Ischemic Stroke: A Case of Suspected Catastrophic Antiphospholipid Syndrome

Catastrophic Antiphospholipid Syndrome: A Life-Threatening Condition

Hematological features and alternate diagnoses in critically ill thrombotic antiphospholipid syndrome patients

The diagnosis and clinical management of the catastrophic antiphospholipid syndrome: A comprehensive review

On Topology of Sensor Networks Deployed for Tracking

Catastrophic antiphospholipid syndrome and pregnancy. Clinical report

Catastrophic Antiphospholipid Syndrome in a Lupus Patient With Severe Recurrent Life-Threatening Clinical Manifestations

The Issue of the Antiphospholipid Antibody Syndrome

Catastrophic antiphospholipid syndrome triggered by fulminant disseminated herpes simplex infection in a patient with systemic lupus erythematosus

Comparison of adjusted-dose vs standard-dose OKT3 therapy of acute rejection in pediatric kidney transplant recipients.

Catastrophic Antiphospholipid Syndrome: A Review of Current Evidence and Future Management Practices

Cutaneous gangrene of the arms and legs after cardiopulmonary resuscitation: A rare presentation of catastrophic antiphospholipid syndrome.